Searched for
THE LANCET RHEUMATOLOGY
Study reveals a simple technique to ease knee arthritis pain, and it can be as effective as medication: What is gait retraining?A new study in The Lancet Rheumatology suggests gait retraining — making subtle changes to walking patterns — can ease knee osteoarthritis ...- Arthritis pain relief without drugs or surgery, study suggestsArthritis, a disorder affecting nearly one in four adults over 40, remains a resulting source of constant pain and disability. Osteoarthrit...
- Can a simple mental shift cure chronic back pain? New scientific study reveals breakthrough in pain reliefA new study from Australia suggests a novel approach to chronic back pain. Cognitive Functional Therapy or CFT can reduce pain and disabili...
- Patients with chronic joint & muscle disorders to increase by 115 % by 2050The musculoskeletal disorders were prevalent at 47.4 per cent higher in women than in men and increased with age to peak at 65-69 years in ...
- Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet studyA recent study published in The Lancet Rheumatology journal predicts that nearly one billion people worldwide will be living with osteoarth...
- One billion people globally to have osteoarthritis by 2050: Lancet StudyBy 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rh...
- Over 840 million people to suffer from back pain; Why?More than 840 million people worldwide will suffer back pain by 2050, largely due to population increase and the ageing people, according t...
- Long Covid symptoms in children can last for 2 months, say expertsExperts stress there is no need to panic, but early treatment is crucial.
- Hybrid immunity effective in preventing Omicron spread, finds new study led by Kerala doctorThe research data was published in Lancet Rheumatology in November.
- Anti-inflammatory drug Ibuprofen does not worsen Covid symptoms, says studyThe study found that the drugs "do not increase the mortality or severity" of Covid-19.
- Tocilizumab may improve survival in sickest COVID-19 patients, scientists sayAmong other treatments, they said tocilizumab was considered for off-label usage for the patients whose respiratory symptoms were declining...
Load More
